PLGA nanoparticles introduction into mitoxantrone-loaded ultrasound-responsive liposomes: In vitro and in vivo investigations
- PMID: 28559216
- DOI: 10.1016/j.ijpharm.2017.05.059
PLGA nanoparticles introduction into mitoxantrone-loaded ultrasound-responsive liposomes: In vitro and in vivo investigations
Abstract
A novel ultrasound-responsive liposomal system for tumor targeting was prepared in order to increase the antitumor efficacy and decrease serious side effects. In this paper, PLGA nanoparticles were used ultrasound-responsive agents instead of conventional microbubbles. The PLGA-nanoparticles were prepared by an emulsion solvent evaporation method. The liposomes were prepared by a lipid film hydration method. Particle size, zeta potential, encapsulation efficiency and drug loading capacity of the liposomes were studied by light scattering analysis and dialysis. Transmission electron microscopy (TEM) and atomic force microscope (AFM) were used to investigate the morphology of liposomes. The release in vitro was carried out in the pH 7.4 phosphate buffer solutions, as a result, liposome L3 encapsulating PLGA-nanoparticles displayed good stability under simulative physiological conditions and quickly responsive release under the ultrasound. The release in vivo was carried out on the rats, as a result, liposome L3 showed higher bioavailability than traditional intravenous injectable administration, and liposome L3 showed higher elimination ratio after stimulation by ultrasound than L3 without stimulation. Thus, the novel ultrasound-responsive liposome encapsulating PLGA-nanoparticles has a potential to be developed as a new drug delivery system for anti-tumor drug.
Keywords: Controlled release; Liposome; Mitoxantrone hydrochloride; PLGA nanoparticles; Release in vitro and in vivo; Ultrasound response.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
PLGA/liposome hybrid nanoparticles for short-chain ceramide delivery.Pharm Res. 2014 Mar;31(3):684-93. doi: 10.1007/s11095-013-1190-5. Epub 2013 Sep 25. Pharm Res. 2014. PMID: 24065591 Free PMC article.
-
[Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].Yao Xue Xue Bao. 2013 May;48(5):759-66. Yao Xue Xue Bao. 2013. PMID: 23888702 Chinese.
-
Co-administration with cell penetrating peptide enhances the oral bioavailability of docetaxel-loaded nanoparticles.Drug Dev Ind Pharm. 2015 May;41(5):764-71. doi: 10.3109/03639045.2014.902465. Epub 2014 Mar 26. Drug Dev Ind Pharm. 2015. PMID: 24669977
-
Liposomes as a Promising Ultrasound-Triggered Drug Delivery System in Cancer Treatment.Curr Mol Med. 2017;17(10):668-688. doi: 10.2174/1566524018666180416100142. Curr Mol Med. 2017. PMID: 29663885 Review.
-
Stimuli-responsive liposomes for drug delivery.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Sep;9(5):10.1002/wnan.1450. doi: 10.1002/wnan.1450. Epub 2017 Feb 15. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017. PMID: 28198148 Free PMC article. Review.
Cited by
-
Anticancer Drugs: Recent Strategies to Improve Stability Profile, Pharmacokinetic and Pharmacodynamic Properties.Molecules. 2022 Aug 25;27(17):5436. doi: 10.3390/molecules27175436. Molecules. 2022. PMID: 36080203 Free PMC article. Review.
-
Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment.ACS Pharmacol Transl Sci. 2021 Jun 1;4(3):1028-1049. doi: 10.1021/acsptsci.1c00066. eCollection 2021 Jun 11. ACS Pharmacol Transl Sci. 2021. PMID: 34151199 Free PMC article. Review.
-
Harnessing the Potential of PLGA Nanoparticles for Enhanced Bone Regeneration.Pharmaceutics. 2024 Feb 15;16(2):273. doi: 10.3390/pharmaceutics16020273. Pharmaceutics. 2024. PMID: 38399327 Free PMC article. Review.
-
Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer.AAPS PharmSciTech. 2023 Dec 14;24(8):258. doi: 10.1208/s12249-023-02712-7. AAPS PharmSciTech. 2023. PMID: 38097825 Review.
-
Multiseed liposomal drug delivery system using micelle gradient as driving force to improve amphiphilic drug retention and its anti-tumor efficacy.Drug Deliv. 2018 Nov;25(1):611-622. doi: 10.1080/10717544.2018.1440669. Drug Deliv. 2018. PMID: 29493300 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous